Overview

A Study of LY900014 in a Medtronic Pump

Status:
Completed

Trial end date:
2019-10-07

Target enrollment:

Participant gender:

Summary

The purpose of this study is to compare the study drug LY900014 to insulin lispro (Humalog) when both are delivered by the Medtronic MiniMed 670G System in adults with type 1 diabetes (T1D). The study will consist of two treatment periods of 4 weeks.

Phase:

Phase 2

Details

Lead Sponsor:

Eli Lilly and Company

Treatments:

Insulin
Insulin Lispro
Insulin, Globin Zinc